84 related articles for article (PubMed ID: 23707077)
1. Atorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression.
Yongjun Y; Shuyun H; Lei C; Xiangrong C; Zhilin Y; Yiquan K
J Neuroimmunol; 2013 Jul; 260(1-2):1-8. PubMed ID: 23707077
[TBL] [Abstract][Full Text] [Related]
2. Glioma-mediated microglial activation promotes glioma proliferation and migration: roles of Na+/H+ exchanger isoform 1.
Zhu W; Carney KE; Pigott VM; Falgoust LM; Clark PA; Kuo JS; Sun D
Carcinogenesis; 2016 Sep; 37(9):839-851. PubMed ID: 27287871
[TBL] [Abstract][Full Text] [Related]
3. The mechanical and pharmacological regulation of glioblastoma cell migration in 3D matrices.
Kaphle P; Li Y; Yao L
J Cell Physiol; 2019 Apr; 234(4):3948-3960. PubMed ID: 30132879
[TBL] [Abstract][Full Text] [Related]
4. Microglia-Derived Olfactomedin-like 3 Promotes Pro-Tumorigenic Microglial Function and Malignant Features of Glioma Cells.
Toedebusch RG; Lucchesi CA; Debebe ET; Wittenburg LA; Chen X; Toedebusch CM
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884869
[TBL] [Abstract][Full Text] [Related]
5. CCL5 of glioma-associated microglia/macrophages regulates glioma migration and invasion via calcium-dependent matrix metalloproteinase 2.
Yu-Ju Wu C; Chen CH; Lin CY; Feng LY; Lin YC; Wei KC; Huang CY; Fang JY; Chen PY
Neuro Oncol; 2020 Feb; 22(2):253-266. PubMed ID: 31593589
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth.
Rivera-Ramos A; Cruz-Hernández L; Talaverón R; Sánchez-Montero MT; García-Revilla J; Mulero-Acevedo M; Deierborg T; Venero JL; Sarmiento Soto M
Cancer Lett; 2024 Jun; 591():216879. PubMed ID: 38636895
[TBL] [Abstract][Full Text] [Related]
7. Microglial-stimulation of glioma invasion involves the EGFR ligand amphiregulin.
Coniglio SJ; Segall JE
PLoS One; 2021; 16(11):e0260252. PubMed ID: 34843542
[TBL] [Abstract][Full Text] [Related]
8. Wasl is crucial to maintain microglial core activities during glioblastoma initiation stages.
Mazzolini J; Le Clerc S; Morisse G; Coulonges C; Zagury JF; Sieger D
Glia; 2022 Jun; 70(6):1027-1051. PubMed ID: 35194846
[TBL] [Abstract][Full Text] [Related]
9. Statin use and survival following glioblastoma multiforme.
Gaist D; Hallas J; Friis S; Hansen S; Sørensen HT
Cancer Epidemiol; 2014 Dec; 38(6):722-7. PubMed ID: 25455652
[TBL] [Abstract][Full Text] [Related]
10. Statins: a repurposed drug to fight cancer.
Jiang W; Hu JW; He XR; Jin WL; He XY
J Exp Clin Cancer Res; 2021 Jul; 40(1):241. PubMed ID: 34303383
[TBL] [Abstract][Full Text] [Related]
11. Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer.
Brown JR; Chan DK; Shank JJ; Griffith KA; Fan H; Szulawski R; Yang K; Reynolds RK; Johnston C; McLean K; Uppal S; Liu JR; Cabrera L; Taylor SE; Orr BC; Modugno F; Mehta P; Bregenzer M; Mehta G; Shen H; Coffman LG; Buckanovich RJ
JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369446
[TBL] [Abstract][Full Text] [Related]
12. Reduced Protumorigenic Tumor-Associated Macrophages With Statin Use in Premalignant Human Lung Adenocarcinoma.
Al Dujaily E; Baena J; Das M; Sereno M; Smith C; Kamata T; Officer L; Pritchard C; Le Quesne J
JNCI Cancer Spectr; 2020 Apr; 4(2):pkz101. PubMed ID: 32190817
[TBL] [Abstract][Full Text] [Related]
13. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.
Bahrambeigi S; Shafiei-Irannejad V
Biochem Pharmacol; 2020 Apr; 174():113787. PubMed ID: 31884044
[TBL] [Abstract][Full Text] [Related]
14. Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects.
Kamarudin MNA; Sarker MMR; Zhou JR; Parhar I
J Exp Clin Cancer Res; 2019 Dec; 38(1):491. PubMed ID: 31831021
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Metabolic Response to Statin-Mediated Oxidative Stress Produces a Synergistic Antitumor Response.
McGregor GH; Campbell AD; Fey SK; Tumanov S; Sumpton D; Blanco GR; Mackay G; Nixon C; Vazquez A; Sansom OJ; Kamphorst JJ
Cancer Res; 2020 Jan; 80(2):175-188. PubMed ID: 31562248
[TBL] [Abstract][Full Text] [Related]
16. The multifaceted effects of metformin on tumor microenvironment.
Kurelac I; Umesh Ganesh N; Iorio M; Porcelli AM; Gasparre G
Semin Cell Dev Biol; 2020 Feb; 98():90-97. PubMed ID: 31091466
[TBL] [Abstract][Full Text] [Related]
17. Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells.
Petővári G; Hujber Z; Krencz I; Dankó T; Nagy N; Tóth F; Raffay R; Mészáros K; Rajnai H; Vetlényi E; Takács-Vellai K; Jeney A; Sebestyén A
Cancer Cell Int; 2018; 18():211. PubMed ID: 30574020
[TBL] [Abstract][Full Text] [Related]
18. Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells.
Saini N; Yang X
Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):133-143. PubMed ID: 29342230
[TBL] [Abstract][Full Text] [Related]
19. The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation.
Blom K; Senkowski W; Jarvius M; Berglund M; Rubin J; Lenhammar L; Parrow V; Andersson C; Loskog A; Fryknäs M; Nygren P; Larsson R
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):199-210. PubMed ID: 28472897
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic effect of atorvastatin in glioblastoma spheroids tumor cultured in fibrin gel.
Bayat N; Ebrahimi-Barough S; Norouzi-Javidan A; Saberi H; Tajerian R; Ardakan MMM; Shirian S; Ai A; Ai J
Biomed Pharmacother; 2016 Dec; 84():1959-1966. PubMed ID: 27836464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
